Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hernandez, Jorge Ravelo
NCT06098079: Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)	Recruiting	4	8600	US	Naltrexone-Bupropion (NB) Combination, Placebo	Currax Pharmaceuticals	Obesity	01/29	07/29
NCT06013813: Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI	Recruiting	N/A	2922	RoW	Radial Artery approach on percutaneous coronary intervention (PCI)	Instituto Nacional de Cardiologia Ignacio Chavez	STEMI - ST Elevation Myocardial Infarction, Myocardial Infarction, Acute Coronary Syndrome	12/24	02/25
Roelant, Geoffrey
NCT06098079: Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)	Recruiting	4	8600	US	Naltrexone-Bupropion (NB) Combination, Placebo	Currax Pharmaceuticals	Obesity	01/29	07/29